Guse Andreas H
The Calcium Signalling Group, Department of Biochemistry and Signal Transduction and Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Cold Spring Harb Protoc. 2013 Jun 1;2013(6):574-8. doi: 10.1101/pdb.prot073015.
As a ubiquitous second messenger, the Ca(2+) mobilizing activity of cyclic ADP-ribose (cADPR) has been observed in many different cell types. The measurement of Ca(2+) release evoked by cADPR comprises several practical challenges. At physiological pH, cADPR has a net negative charge and it therefore cannot cross the cell membrane in cells that lack a suitable cADPR-transporting system. Thus, either the plasma membrane must be permeabilized or microinjection must be used to deliver cADPR to the cytosol. In this article, two methods for cADPR delivery (using permeabilized cells or microinjection) are explained step-by-step. Because most of our work has been performed using the Jurkat T-lymphoma cell line, the methods are tailored for this specific cell type. For other cell types, the procedures may need to be adapted.
作为一种普遍存在的第二信使,环二磷酸腺苷核糖(cADPR)的钙离子动员活性已在许多不同细胞类型中被观察到。测量由cADPR诱发的钙离子释放存在几个实际挑战。在生理pH值下,cADPR带有净负电荷,因此在缺乏合适的cADPR转运系统的细胞中,它无法穿过细胞膜。因此,要么使质膜通透,要么必须使用显微注射将cADPR递送至细胞质溶胶。在本文中,将逐步解释两种cADPR递送方法(使用通透细胞或显微注射)。由于我们的大部分工作是使用Jurkat T淋巴瘤细胞系进行的,因此这些方法是针对这种特定细胞类型量身定制的。对于其他细胞类型,可能需要调整这些程序。